| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |